ENTRY       D11122                      Drug
NAME        Letolizumab (USAN/INN)
FORMULA     C1734H2688N466O538S10
EXACT_MASS  38967.4509
MOL_WEIGHT  38991.3459
SEQUENCE    EVQLLESGGG LVQPGGSLRL SCAASGFTFN WELMGWARQA PGKGLEWVSG IEGPGDVTYY
            ADSVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCVKVG KDAKSDYRGQ GTLVTVSSAS
            TEPKSSDKTH TSPPSPAPEL LGGSSVFLFP PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK
            FNWYVDGVEV HNAKTKPREE QYNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKALPAPIEK
            TISKAKGQPR EPQVYTLPPS RDELTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT
            PPVLDSDGSF FLYSKLTVDK SRWQQGNVFS CSVMHEALHN HYTQKSLSLS PGK
            (Disulfide bridge: 22-96, 167-227, 273-331)
  TYPE      Peptide
EFFICACY    Anti-inflammatory, Anti-CD154 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of inflammatory disease
TARGET      TNFSF5 (CD154) [HSA:959] [KO:K03161]
  PATHWAY   hsa04060(959)  Cytokine-cytokine receptor interaction
            hsa04064(959)  NF-kappa B signaling pathway
            hsa04660(959)  T cell receptor signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Tumor necrosis factors
                TNFSF5 (CD154)
                 D11122  Letolizumab (USAN/INN)
DBLINKS     CAS: 1450981-87-9
            PubChem: 376219046
///
